Drug Type Diagnostic radiopharmaceuticals |
Synonyms- |
Target- |
Mechanism PET imaging(Positron-emission tomography enhancers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Prostatic Cancer | Phase 3 | - | 01 Aug 2024 | |
Prostatic Cancer | Phase 3 | - | 01 Aug 2024 | |
Prostatic Cancer | Phase 3 | - | 01 Aug 2024 | |
Prostatic Cancer | Phase 3 | - | 01 Aug 2024 |